Multiple Myeloma Industry Market Set to Register healthy CAGR During 2020-2025 The ‘Multiple Myeloma Industry Market’ research report added by Market Study Report, LLC, provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in […]

How can plasma cell leukemia be managed? Saad Usmani, MD, FACP, from the Levine Cancer Institute, Charlotte, NC, discusses the management of the rare myeloma plasma cell leukemia at the 2017 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France. He outlines the definition of plasma cell leukemia, and highlights that there is […]

Multiple Myeloma Drugs Market 2020-2025: Global Size, Share, Price and Research Report According to the latest report by IMARC Group, titled “Multiple Myeloma Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global multiple myeloma drugs market grew at a CAGR of around 9% during 2014-2019. Multiple myeloma, or Kahler’s disease, refers […]

Plasma Cell Dyscrasias Learn about multiple myeloma, MGUS, smoldering myeloma, Waldenstrom’s macroglobulinemia, and more!

Multiple myeloma — blood cancer formed in bone marrow Multiple myeloma is a cancer caused by malignant plasma cells. Plasma cells help the human body fight infection, but when they multiply out of control, the myeloma cells overpower the bone’s healthy cells causing harmful side effects; such as bone fractures and infections. Sheeba Thomas, M.D., […]

Bristol-Myers Squibb Company – Consensus Indicates Potential 17.7% Upside Bristol-Myers Squibb Company with ticker code (BMY) have now 12 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 85 and 64 with the average target price sitting at 73.25. Given that the stocks previous close was at […]

Plasma Cell Dyscrasias | MGUS and Waldenstorm macrogammaglobulinemia simplified | Usmle Hematology | Multiple myeloma (MM), also known as plasma cell myeloma and simple myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Often, no symptoms are noticed initially. As it progresses, bone pain, bleeding, frequent infections, […]

Attacking plasma cell dyscrasia in AL amyloidosis Vaishali Sanchorawala, MD Boston University School of Medicine, Boston, MA, provides an overview into research and current treatments of plasma cell dyscrasia in light chain amyloidosis (AL amyloidosis), speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Global Blood and Bone Marrow Cancer Treatment Market Research Study 2020 Insights with … Rising number of corona virus cases has impacted numerous lives and led to numerous fatalities, and has affected the overall economic structure globally. The Blood and Bone Marrow Cancer Treatment has analyzed and published the latest report on the global Blood […]

The Effect of Myeloma on the Bone Marrow Myeloma is a cancer arising from plasma cells that are normally found in the bone marrow. The build-up of cancerous plasma cells, or myeloma cells, within the bone marrow can affect its ability to function properly. This animation describes how normal bone marrow makes red blood cells, […]